Giuseppe Curigliano

机构：University of Milan, Istituto Oncologico Veneto, Istituti di Ricovero e Cura a Carattere Scientifico, European Institute of Oncology · ORCID：0000-0003-1781-2518

发表论文 1695 篇 · 总被引 73057 次 · h-index 118

代表论文

• A deep learning framework for efficient pathology image analysis (2026 · Nature Communications · 被引 3)
• Evolving roles of liquid biopsy in precision medicine for colorectal cancer: from single-gene analysis to broad genomic profiling (2026 · Nature Reviews Clinical Oncology · 被引 2)
• Interplay between HER2-Low status, hormone receptor expression, and therapeutic response to cyclin-dependent kinase 4/6 inhibitors as first-line treatment in luminal-like metastatic breast cancer: The CYCLHER study (2026 · The Breast · 被引 1)
• How can we determine suitable combination immunotherapies for cancer by looking at the molecular targeting of each therapy? (2026 · Expert Opinion on Investigational Drugs)
• HER2DX in early-stage HER2-positive breast cancer: a review of clinical utility (2026 · ESMO Open)
• Minimal Residual Disease via circulating tumor DNA Predicts Exceptional Response in HER2-Positive Metastatic Breast Cancer (2026 · medRxiv)